PUBLISHER: Grand View Research | PRODUCT CODE: 1362936
PUBLISHER: Grand View Research | PRODUCT CODE: 1362936
The global specialty enzymes market size is expected to reach USD 8.88 billion by 2030, as per the new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 6.6% from 2023 to 2030. This is attributable to the specific yield optimization and catalytic reaction properties of specialty enzymes.
Pharmaceutical manufacturers across the globe have incorporated these specialty enzymes on account of their expanding applications particularly in processing fine chemicals and pure pharmaceutical drugs. The shift in trend towards the adoption of specialty enzymes in order to reduce reliance on conventional enzymes has been observed in the last few years and hence these enzymes are expected to penetrate the overall industry growth. Specialty enzymes are widely used to manufacture drugs to treat some fatal diseases such as cardiovascular diseases, cancer, and pain caused by age, asthma, hay fever, and lysosomal storage disorders in the pharmaceutical industry. The increasing prevalence of such diseases coupled with the growing geriatric population particularly in the U.S., Europe, and Japan is also expected to have a positive influence on industry growth.
Growth of the global pharmaceutical industry, growing number of biotechnology R&D, and advancement in enzyme engineering & green chemistry are expected to fuel the market over the forecast period. Difficulty in maintaining pH and operational temperature of specialty enzymes is expected to remain a key concern for key players. Legal & ethical issues coupled to lack of awareness among consumers regarding the benefits of specialty enzymes particularly in developing countries is also expected to pose threat to the market growth. However, the growing industrialization rate and advanced technologies adopted in the pharmaceutical industry in emerging markets of BRIC nations is expected to hold future opportunities for industry participants.
North America emerged as the largest regional specialty enzyme market owing to the presence of niche consumers and advanced technologies. An increase in population and growth in disposable income among consumers in emerging markets of China and India is expected to drive the industry demand in the Asia Pacific region. China, India, and Brazil are expected to be the most lucrative regional markets for specialty enzymes. Some of the key specialty enzyme manufacturers include Advanced Enzyme Technology Ltd. Affymetrix Inc., Advanced Enzyme Technology Ltd., Amano Enzyme Inc., Bbi Enzymes Ltd., Basf, Codexis Inc., Nagase & Co. Ltd., Life Technologies, Roche Holding Ag., and Sanofi S.A among others.